Dr. James Ford, MD

Molecular Profiling of Gastric Cancer: Toward Persolized Cancer Medicine

JOURL OF CLINICAL ONCOLOGY, 2013

Lupus Antibody Tops Cancer Cells

SCIENCE TRANSLATIOL MEDICINE, 2012

Lynch Syndrome in Patients With Colorectal Cancer Finding the Needle in the Haystack

JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2012

Long-Term Survivors of Gastric Cancer: A California Population-Based Study

JOURL OF CLINICAL ONCOLOGY, 2012

Genetic Testing by Cancer Site Stomach

CANCER JOURL, 2012

Breast cancers with compromised D repair exhibit selective sensitivity to elesclomol

D REPAIR, 2012

Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost

ANLS OF INTERL MEDICINE, 2011

Second Primary Breast Cancer Occurrence According to Hormone Receptor Status

JOURL OF THE TIOL CANCER INSTITUTE, 2009

Defective Repair of Oxidative D Damage in Triple

CANCER RESEARCH, 2009

Performance of BRCA1/2 mutation prediction models in Asian Americans

JOURL OF CLINICAL ONCOLOGY, 2008

CDH1 truncating mutations in the E-cadherin gene

ANLS OF SURGERY, 2007

Predicting and preventing hereditary colorectal cancer

JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2006

Molecular inversion probe alysis of gene copy alterations reveals distinct categories of colorectal

CANCER RESEARCH, 2006

Opposing effects of the UV lesion repair protein XPA

EMBO JOURL, 2006

In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product

JOURL OF BIOLOGICAL CHEMISTRY, 2003

p53 and regulation of D damage recognition during nucleotide excision repair

D REPAIR, 2003

The DDB2 nucleotide excision repair gene product p48 enhances global genomic repair

D REPAIR, 2003

p53 and D damage-inducible expression of the xeroderma pigmentosum group C gene

PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2002

BRCA1 induces D damage recognition factors and enhances nucleotide excision repair

TURE GENETICS, 2002

Expression of the p48 xeroderma pigmentosum gene is p53-dependent

PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1999

Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in

JOURL OF BIOLOGICAL CHEMISTRY, 1997

LI-FRAUMENI SYNDROME FIBROBLASTS HOMOZYGOUS FOR P53 MUTATIONS ARE DEFICIENT IN GLOBAL D

PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1995

Dymic contrast-enhanced MRI

Jourl of the American Medical Informatics Association, 2013

A young woman with bilateral breast cancer

Jourl of the tiol Comprehensive Cancer Network, 2013

Seventh Edition (2010) of the AJCC

ANLS OF SURGICAL ONCOLOGY, 2013

Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early

JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2012

Single Cell Profiling of Circulating Tumor Cells

PLOS ONE, 2012

Family History As a Positive Prognostic Factor in Gastric Cancer

JOURL OF CLINICAL ONCOLOGY, 2012

Identification of a Functiol In Vivo p53 Response Element

Genes & cancer, 2012

A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer

ANLS OF SURGICAL ONCOLOGY, 2011

Intensity-Modulated Radiation Therapy Versus Conventiol Radiation Therapy for Squamous Cell

CANCER, 2011

Comparison of Intensity-Modulated Radiotherapy

Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No, 2010

(18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

Oncogenic BRAF Mutation with CDKN2A Ictivation Is Characteristic of a Subset of Pediatric Malignt

CANCER RESEARCH, 2010

Identification of a biomarker panel using a multiplex proximity ligation

JOURL OF TRANSLATIOL MEDICINE, 2009

The role of the retinoblastoma

D REPAIR, 2009

Gemcitabine chemotherapy

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

Microsatellite instability

AMERICAN JOURL OF SURGICAL PATHOLOGY, 2008

Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1)

AMERICAN JOURL OF SURGICAL PATHOLOGY, 2008

Magnetic resonce galactography

BREAST JOURL, 2008

HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombition

PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2007

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer

JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2007

Ductal pattern enhancement on magnetic resonce imaging of the breast due to ductal lavage

BREAST JOURL, 2007

A kise-independent function of c

MOLECULAR CELL, 2006

Colorectal Cancer Screening Clinical Practice Guidelines.

Jourl of the tiol Comprehensive Cancer Network, 2006

Phase II study to assess the efficacy of conventiolly fractioted radiotherapy followed by a

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

Regulation of D damage recognition and nucleotide excision repair: Another role for p53

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005

Phase II study of gefitinib, fluorouracil

JOURL OF CLINICAL ONCOLOGY, 2005

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

Breast magnetic resonce image screening

CANCER, 2004

Functiol characterization of global genomic D repair and its implications for cancer

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2003

BRCA1 and p53: compensatory roles in D repair

JOURL OF MOLECULAR MEDICINE-JMM, 2003

Defective double-strand D break repair and chromosomal translocations by MYC overexpression

PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2003

Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003

D Damage, Repair, and Diseases.

Jourl of biomedicine & biotechnology, 2002

The p53-regulated cyclin-dependent kise inhibitor

JOURL OF BIOLOGICAL CHEMISTRY, 2001

Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5

AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001

Preoperative chemoradiation for margilly resectable adenocarcinoma of the pancreas

Mehta, V. K., Fisher, G., Ford, J. A., Poen, J. C., Vierra, M. A., Obe, 2001

Adjuvant chemoradiotherapy for unfavorable carcinoma of the ampulla of vater - Prelimiry report

ARCHIVES OF SURGERY, 2001

Adjuvant radiotherapy

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000

Decreased UV sensitivity

MUTATION RESEARCH-D REPAIR, 2000

p53-mediated D repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and

MOLECULAR AND CELLULAR BIOLOGY, 2000

Chemoradiotherapy in the magement of localized tumors of the pancreas

ANLS OF SURGICAL ONCOLOGY, 1999

Hepatitis B x protein inhibits p53-dependent D repair in primary mouse hepatocytes

JOURL OF BIOLOGICAL CHEMISTRY, 1998

Role of D excision repair gene defects in the etiology of cancer

GENETIC INSTABILITY AND TUMORIGENESIS, 1997

Experimental reversal of P-glycoprotein

EUROPEAN JOURL OF CANCER, 1996

PREFERENTIAL REPAIR OF ULTRAVIOLET LIGHT-INDUCED D

MOLECULAR CARCINOGENESIS, 1994

MODULATION OF RESISTANCE TO ALKYLATING-AGENTS IN CANCER CELL BY GOSSYPOL ENTIOMERS

CANCER LETTERS, 1991

BIOCHEMICAL CORRELATES OF THE ANTITUMOR AND ANTIMITOCHONDRIAL PROPERTIES OF GOSSYPOL ENTIOMERS

MOLECULAR PHARMACOLOGY, 1990

TOREMIFENE - PHARMACOLOGIC AND PHARMACOKINETIC BASIS OF REVERSING MULTIDRUG RESISTANCE

JOURL OF CLINICAL ONCOLOGY, 1989

Molecular Profiling of Gastric Cancer: Toward Personalized Cancer Medicine

JOURNAL OF CLINICAL ONCOLOGY, 2013

Lupus Antibody Tops Cancer Cells

SCIENCE TRANSLATIONAL MEDICINE, 2012

Lynch Syndrome in Patients With Colorectal Cancer Finding the Needle in the Haystack

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012

Long-Term Survivors of Gastric Cancer: A California Population-Based Study

JOURNAL OF CLINICAL ONCOLOGY, 2012

Genetic Testing by Cancer Site Stomach

CANCER JOURNAL, 2012

Breast cancers with compromised DNA repair exhibit selective sensitivity to elesclomol

DNA REPAIR, 2012

Is breast cancer a part of Lynch syndrome?

Breast cancer research : BCR, 2012

Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer A Cost

ANNALS OF INTERNAL MEDICINE, 2011

Enhanced sensitivity to cisplatin

BMC pharmacology, 2011

Synergistic Chemosensitivity of Triple-Negative Breast Cancer Cell Lines to Poly

CANCER RESEARCH, 2010

Second Primary Breast Cancer Occurrence According to Hormone Receptor Status

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009

Defective Repair of Oxidative DNA Damage in Triple

CANCER RESEARCH, 2009

Performance of BRCA1/2 mutation prediction models in Asian Americans

JOURNAL OF CLINICAL ONCOLOGY, 2008

Hereditary diffuse gastric cancer - Implications of genetic testing for screening

CANCER, 2008

CDH1 truncating mutations in the E-cadherin gene

ANNALS OF SURGERY, 2007

Predicting and preventing hereditary colorectal cancer

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006

Molecular inversion probe analysis of gene copy alterations reveals distinct categories of

CANCER RESEARCH, 2006

Opposing effects of the UV lesion repair protein XPA

EMBO JOURNAL, 2006

In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003

p53 and regulation of DNA damage recognition during nucleotide excision repair

DNA REPAIR, 2003

The DDB2 nucleotide excision repair gene product p48 enhances global genomic repair

DNA REPAIR, 2003

p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53

CARCINOGENESIS, 2003

p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2002

BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair

NATURE GENETICS, 2002

Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis

MOLECULAR CELL, 2000

Expression of the p48 xeroderma pigmentosum gene is p53-dependent

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1999

Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in

JOURNAL OF BIOLOGICAL CHEMISTRY, 1997

LI-FRAUMENI SYNDROME FIBROBLASTS HOMOZYGOUS FOR P53 MUTATIONS ARE DEFICIENT IN GLOBAL DNA

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1995

A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.

Breast cancer research and treatment, 2013

Dynamic contrast-enhanced MRI

Journal of the American Medical Informatics Association, 2013

A young woman with bilateral breast cancer

Journal of the National Comprehensive Cancer Network, 2013

Seventh Edition (2010) of the AJCC

ANNALS OF SURGICAL ONCOLOGY, 2013

Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations

FAMILIAL CANCER, 2012

Chest Wall Leiomyosarcoma After Breast-Conservative Therapy for Early

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012

Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma

MODERN PATHOLOGY, 2012

Single Cell Profiling of Circulating Tumor Cells

PLOS ONE, 2012

Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma

Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., , 2012

Family History As a Positive Prognostic Factor in Gastric Cancer

JOURNAL OF CLINICAL ONCOLOGY, 2012

Identification of a Functional In Vivo p53 Response Element

Genes & cancer, 2012

Identification of a novel deletion mutant strain in Saccharomyces cerevisiae that results in a

BioDiscovery

HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012

A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer

ANNALS OF SURGICAL ONCOLOGY, 2011

Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell

CANCER, 2011

A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal

MODERN PATHOLOGY, 2011

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry

BREAST CANCER RESEARCH AND TREATMENT, 2011

Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate

Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., 2010

Poly(ADP-Ribose) Polymerase Inhibition: Targeted Therapy for Triple-Negative Breast Cancer

CLINICAL CANCER RESEARCH, 2010

PARP inhibitors in breast cancer.

Clinical advances in hematology & oncology : H&O, 2010

Comparison of Intensity-Modulated Radiotherapy

Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No, 2010

(18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation

HUMAN PATHOLOGY, 2010

Pathological response after chemoradiation for T3 rectal cancer

COLORECTAL DISEASE, 2010

Pathological response after chemoradiation for T3 rectal cancer.

Colorectal disease, 2010

Novel Treatment Approaches for Triple-Negative Breast Cancer

CLINICAL BREAST CANCER, 2010

Longer Relative Telomere Length in Blood from Women with Sporadic

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010

Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric

CANCER RESEARCH, 2010

PARP Inhibitors for the Treatment and Prevention of Breast Cancer.

Current breast cancer reports, 2010

Multimodality treatment with intensity modulated radiation therapy for esophageal cancer

DISEASES OF THE ESOPHAGUS, 2010

Identification of a biomarker panel using a multiplex proximity ligation

JOURNAL OF TRANSLATIONAL MEDICINE, 2009

A BRCA2 founder mutation

BREAST CANCER RESEARCH AND TREATMENT, 2009

The role of the retinoblastoma

DNA REPAIR, 2009

Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT

CLINICAL NUCLEAR MEDICINE, 2009

Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas

CANCER, 2009

Gemcitabine chemotherapy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

Microsatellite instability

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008

Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers

FAMILIAL CANCER, 2008

Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1)

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008

Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family

FAMILIAL CANCER, 2008

Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family

PEDIATRIC BLOOD & CANCER, 2008

Magnetic resonance galactography

BREAST JOURNAL, 2008

HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2007

A carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature

CANCER GENETICS AND CYTOGENETICS, 2007

Identification of an intronic single nucleotide polymorphism leading to allele dropout during

GENETICS IN MEDICINE, 2007

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007

Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage

BREAST JOURNAL, 2007

Reversal of stathmin-mediated resistance to paclitaxel

MOLECULAR PHARMACOLOGY, 2007

Germ line mutations of mismatch repair genes

CLINICAL CANCER RESEARCH, 2006

A kinase-independent function of c

MOLECULAR CELL, 2006

Colorectal Cancer Screening Clinical Practice Guidelines.

Journal of the National Comprehensive Cancer Network, 2006

Genetic/familial high-risk assessment: breast and ovarian.

Daly, M. B., Axilbund, J. E., Bryant, E., Buys, S., Eng, C., Friedman,

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

Regulation of DNA damage recognition and nucleotide excision repair: Another role for p53

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005

Opinions of women with high inherited breast cancer risk about prophylactic mastectomy

HEALTH EXPECTATIONS, 2005

Phase II study of gefitinib, fluorouracil

JOURNAL OF CLINICAL ONCOLOGY, 2005

Characterization of a recurrent germ line mutation of the E-cadherin gene

CLINICAL CANCER RESEARCH, 2005

Ductal lavage of fluid-yielding and non

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

Breast magnetic resonance image screening

CANCER, 2004

Functional characterization of global genomic DNA repair and its implications for cancer

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2003

BRCA1 and p53: compensatory roles in DNA repair

JOURNAL OF MOLECULAR MEDICINE-JMM, 2003

Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2003

Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003

DNA Damage, Repair, and Diseases.

Journal of biomedicine & biotechnology, 2002

The p53-regulated cyclin-dependent kinase inhibitor

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001

Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001

Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil

Mehta, V. K., Poen, J., Ford, J., Edelstein, P. S., Vierra, M., Bastid, 2001

Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas

Mehta, V. K., Fisher, G., Ford, J. A., Poen, J. C., Vierra, M. A., Obe, 2001

Adjuvant chemoradiotherapy for unfavorable carcinoma of the ampulla of vater - Preliminary report

ARCHIVES OF SURGERY, 2001

Adjuvant radiotherapy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000

Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53

MOLECULAR AND CELLULAR BIOLOGY, 2000

Reduced global genomic repair of ultraviolet light

MOLECULAR CARCINOGENESIS, 2000

Decreased UV sensitivity

MUTATION RESEARCH-DNA REPAIR, 2000

p53-mediated DNA repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and

MOLECULAR AND CELLULAR BIOLOGY, 2000

Chemoradiotherapy in the management of localized tumors of the pancreas

ANNALS OF SURGICAL ONCOLOGY, 1999

Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998

Human fibroblasts expressing the human papillomavirus E6 gene are deficient

CANCER RESEARCH, 1998

Role of DNA excision repair gene defects in the etiology of cancer

GENETIC INSTABILITY AND TUMORIGENESIS, 1997

Experimental reversal of P-glycoprotein

EUROPEAN JOURNAL OF CANCER, 1996

P-glycoprotein-mediated multidrug resistance

Cancer treatment and research, 1996

MODULATORS OF MULTIDRUG-RESISTANCE - PRECLINICAL STUDIES

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1995

PREFERENTIAL REPAIR OF ULTRAVIOLET LIGHT-INDUCED DNA

MOLECULAR CARCINOGENESIS, 1994

PHARMACOLOGICAL CIRCUMVENTION OF MULTIDRUG-RESISTANCE

CYTOTECHNOLOGY, 1993

EFFECT OF BUTHIONINE SULFOXIMINE ON TOXICITY OF VERAPAMIL AND DOXORUBICIN TO MULTIDRUG RESISTANT

CANCER RESEARCH, 1991

MODULATION OF RESISTANCE TO ALKYLATING-AGENTS IN CANCER CELL BY GOSSYPOL ENANTIOMERS

CANCER LETTERS, 1991

PHARMACOLOGY OF DRUGS THAT ALTER MULTIDRUG RESISTANCE IN CANCER

PHARMACOLOGICAL REVIEWS, 1990

BIOCHEMICAL CORRELATES OF THE ANTITUMOR AND ANTIMITOCHONDRIAL PROPERTIES OF GOSSYPOL ENANTIOMERS

MOLECULAR PHARMACOLOGY, 1990

CELLULAR AND BIOCHEMICAL

CANCER RESEARCH, 1990

TOREMIFENE - PHARMACOLOGIC AND PHARMACOKINETIC BASIS OF REVERSING MULTIDRUG RESISTANCE

JOURNAL OF CLINICAL ONCOLOGY, 1989

STRUCTURAL FEATURES DETERMINING ACTIVITY OF PHENOTHIAZINES AND RELATED DRUGS FOR INHIBITION OF CELL

MOLECULAR PHARMACOLOGY, 1989